(Q45387928)

English

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Antoni Payeras-Cifre

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Montserrat Laguno

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Carmen Cifuentes

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Javier Murillas

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sergio Veloso

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Maria Larrousse

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Lucia Bonet

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Antoni Bassa

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Concha Villalonga

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Iñaki Pérez

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cristina Tural

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Maria Martínez-Rebollar

14

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marta Calvo

15

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jose Luis Blanco

16

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Estaban Martínez

17

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jose M Sánchez-Tapias

18

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jose M Gatell

19

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jose Mallolas

20

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

22-31

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Hepatitis C in the HIV-Infected Person

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

21 January 2018

Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22598

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22598

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45387928&oldid=2076323973"